Task: Answer the multiple choice question.
Query: Which drug has a -8.602\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CN1C(=O)CC(N2CCN(C(=O)CN3CCCC3)CC2)C1=O
(b) Cc1cc2cc(C)c(NCCNC(=O)c3cccs3)nc2cc1C
(c) CC(C)=CCN1CCN(Cc2cc(CC(C)C)n[nH]2)CC1CCO
Answer: a. CN1C(=O)CC(N2CCN(C(=O)CN3CCCC3)CC2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1C(=O)CC(N2CCN(C(=O)CN3CCCC3)CC2)C1=O
CN1C(=O)CC(N2CCN(C(=O)CN3CCCC3)CC2)C1=O
1-methyl-3-[4-(2-pyrrolidin-1-ylacetyl)piperazin-1-yl]pyrrolidine-2,5-dione